Joint disease arising as a manifestation of another specified underlying systemic condition, coded when the affected joint site is not documented or cannot be determined.
Verified May 8, 2026 · 4 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- General
Documentation tips
What should appear in the chart to support M14.80.
Source · Editorial brief grounded in 4 cited references ↓
- Identify and document the specific underlying systemic disease (e.g., hemochromatosis, hypothyroidism) — it must be coded first under the etiology/manifestation convention.
- Record the affected joint location by name (right shoulder, left knee, etc.) so a site-specific M14.81–M14.89 code can replace M14.80; use M14.80 only when site is genuinely undetermined or undocumented.
- Confirm the arthropathy is causally linked to the underlying disease, not incidental — the clinical note should explicitly state or clearly imply the relationship.
- Verify the underlying condition is not in the Excludes1 list (diabetes, sarcoidosis, neoplasm, neurosyphilis, enteropathic arthropathies, etc.) before assigning M14.80.
- For inpatient claims, document whether the arthropathy was present on admission (POA) — this affects POA indicator assignment separate from sequencing.
Related CPT procedures
Procedure codes commonly billed with M14.80. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M14.80 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Listing M14.80 as the first-listed or principal diagnosis — it is a manifestation code and must always be sequenced after the underlying disease code.
- Using M14.80 for diabetic arthropathy — diabetes-related joint disease maps to E08–E13 with .61-, which is an Excludes1 exclusion from the entire M14.8 category.
- Defaulting to M14.80 when a site-specific code exists — if the note documents even a general region (e.g., 'bilateral hands'), use M14.84 (hand) instead.
- Applying M14.80 for arthropathy in sarcoidosis (D86.86), neoplastic disease (M36.1), or enteropathic arthropathy (M07.-) — all are Excludes1 conditions that cannot be coded with M14.8x.
- Failing to link the joint complaint to the systemic diagnosis in the record, leaving the manifestation-to-etiology relationship unsupported for audit purposes.
Clinical context
Source · Editorial summary grounded in 4 cited references ↓
M14.80 is a manifestation code — it represents arthropathy caused by a named systemic disease when the specific joint site is not documented. The parent category M14.8 covers arthropathies secondary to conditions such as amyloidosis (E85.-), hemochromatosis (E83.11-), hyperparathyroidism (E21.-), hypothyroidism (E00–E03), sickle-cell disorders (D57.-), thyrotoxicosis (E05.-), erythema multiforme (L51.-), erythema nodosum (L52), and Whipple's disease (K90.81). The '0' at the 6th character position signals unspecified site — meaning no laterality or joint location was documented.
Because M14.80 is a manifestation code, the etiology/manifestation sequencing rule applies: code the underlying disease first, then M14.80 second. Never list M14.80 as the principal or first-listed diagnosis. If the operative or clinical note identifies a specific joint (e.g., right shoulder, left knee), use the corresponding site-specific code from the M14.81–M14.89 range instead of M14.80.
Several high-traffic diagnoses are explicitly excluded from M14.8 and must be coded elsewhere: diabetic arthropathy (E08–E13 with .61-), arthropathy in hematological disorders (M36.2–M36.3), hypersensitivity reactions (M36.4), neoplastic disease (M36.1), neurosyphilis (A52.16), sarcoidosis (D86.86), enteropathic arthropathies (M07.-), juvenile psoriatic arthropathy (L40.54), and lipoid dermatoarthritis (E78.81). Attempting to use M14.80 for any of these will result in an Excludes1 conflict.
Sibling codes
Other billable codes under M14.8 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 4 cited references ↓
01Can M14.80 ever be the first-listed diagnosis on a claim?
02When should I use M14.80 versus a site-specific M14.8x code?
03Is arthropathy due to diabetes coded with M14.80?
04What underlying diseases most commonly pair with M14.80 in orthopedic practice?
05Does M14.80 require a 7th character?
06What happens if I use M14.80 for a sarcoidosis-related arthropathy?
07How do I handle bilateral involvement when using the M14.8x range?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M14-/M14.80
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M14.80
- 04cms.govhttps://www.cms.gov/Medicare/Coding/ICD10/Downloads/2019-ICD10-Coding-Guidelines-.pdf
Mira AI Scribe
The Mira AI Scribe captures the specific underlying systemic diagnosis (e.g., hemochromatosis, hypothyroidism), the affected joint location and side, any imaging findings supporting inflammatory or destructive joint changes, and the treating provider's documented link between the systemic condition and joint symptoms. Capturing joint site prevents unnecessary fallback to the unspecified M14.80 and supports correct sequencing of the etiology code first — avoiding both downcoded claims and audit flags for unsupported manifestation coding.
See how Mira captures M14.80 documentation